First-In-Human Trial of 64Cu-Sartate PET Imaging of Patients With Neuroendocrine Tumours Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
Journal of Nuclear Medicine - China
doi 10.2967/jnumed.118.217745
Full Text
Open PDFAbstract
Available in full text
Date
November 15, 2018
Authors
Publisher
Society of Nuclear Medicine